Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qompium develops and commercializes FibriCheck, the first CE-marked and FDA-cleared smartphone application that detects heart rhythm disorders using the phone’s camera. The company also operates Extra Horizon, a secure cloud-based platform enabling other companies to rapidly develop compliant medical applications. Both units have seen rapid growth during the COVID pandemic due to increased demand for remote patient monitoring. FibriCheck has been used in large-scale telehealth projects such as TeleCheck-AF with Maastricht UMC+.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qompium.